Malignant Laryngeal Neoplasm — Trials

Malignant Laryngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

275 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 41
Ph III recruiting: 5
Growth YoY: —
Industry share: 2%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%
Trials / 1,000 deaths: 16.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05420597	Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma	unknown	Phase 2	61	Fudan UniversityOTHER	1	Jun 15, 2022	clinicaltrials
NCT04995120	Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma(INSIGHT)	unknown	Phase 2	42	Fudan UniversityOTHER	1	Jan 18, 2022	clinicaltrials